Patents by Inventor Michael AXELSON

Michael AXELSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING COLORECTAL CANCER
    Publication number: 20250026831
    Abstract: This disclosure provides methods for treating a tumor derived from a colorectal cancer exhibiting a high degree of microsatellite instability in a subject comprising administering to the subject an anti-PD-1 antibody. In some embodiments, the method further comprises administering an anti-CTLA-4 antibody. In some embodiments, the colorectal cancer is rectal cancer, colon cancer, or any combination thereof.
    Type: Application
    Filed: July 29, 2024
    Publication date: January 23, 2025
    Applicant: Bristol-Myers Squibb Company
    Inventor: Michael AXELSON
  • METHODS OF TREATING COLORECTAL CANCER
    Publication number: 20220356254
    Abstract: This disclosure provides methods for treating a tumor derived from a colorectal cancer exhibiting a high degree of microsatellite instability in a subject comprising administering to the subject an anti-PD-1 antibody. In some embodiments, the method further comprises administering an anti-CTLA-4 antibody. In some embodiments, the colorectal cancer is rectal cancer, colon cancer, or any combination thereof.
    Type: Application
    Filed: April 19, 2022
    Publication date: November 10, 2022
    Applicant: Bristol-Myers Squibb Company
    Inventor: Michael AXELSON
  • Methods of treating colorectal cancer
    Patent number: 11332529
    Abstract: This disclosure provides methods for treating a tumor derived from a colorectal cancer exhibiting a high degree of microsatellite instability in a subject comprising administering to the subject an anti-PD-1 antibody. In some embodiments, the method further comprises administering an anti-CTLA-4 antibody. In some embodiments, the colorectal cancer is rectal cancer, colon cancer, or any combination thereof.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: May 17, 2022
    Assignee: Bristol-Myers Squibb Company
    Inventor: Michael Axelson
  • USE OF ANTI-PD-1 ANTIBODY IN THE TREATMENT OF PATIENTS WITH COLORECTAL CANCER
    Publication number: 20190153100
    Abstract: This disclosure provides methods for treating a tumor derived from a colorectal cancer exhibiting a high degree of microsatellite instability in a subject comprising administering to the subject an anti-PD-1 antibody. In some embodiments, the method further comprises administering an anti-CTLA-4 antibody. In some embodiments, the colorectal cancer is rectal cancer, colon cancer, or any combination thereof.
    Type: Application
    Filed: June 2, 2017
    Publication date: May 23, 2019
    Applicant: Bristol-Myers Squibb Company
    Inventor: Michael AXELSON